Literature DB >> 15543578

Histone acetyltransferase activity of p300 enhances the activation of IL-18 promoter.

Haijing Sun1, Jun Lu, Xin Xu, Shunzi Jin, Xiuli Wang, Liang Wei, Mei Dong, Baiqu Huang.   

Abstract

Interleukin-18 (IL-18), an important regulator of innate and acquired immune responses expressed from a variety of cell types, is a pleiotropic cytokine in the development of T helper type 1 (Thl) cells. The p300/CBP (CREB-binding protein) coactivator proteins are important histone acetyltransferases (HATs) that regulate the transcription of many genes. Whether p300/CBP play a role in the IL-18 expression has not been investigated previously. In this study, we analyzed the roles of p300 in the regulation of mouse IL-18 by using RT-PCR and a series of co-transfection studies. We showed that p300 had a stimulating effect on the endogenous IL-18 mRNA synthesis and on the activity of IL-18 p1 promoter. The results also showed that IL-18 p1 promoter activity was enhanced by p300 in a dose-dependent manner. Moreover, the p300-mediated activation function can be suppressed by the adenovirus E1A protein, which inhibits the HAT function of p300. Also, a mutation in p300 HAT region abolished the effect of p300 on IL-18 activation. These data further indicate that the acetylase activity of p300 was indispensable to its function. Furthermore, we found that p300 was able to enhance the effect of the transcription factor c-Fos on activation of the IL-18 promoter. Data presented in this paper implicate important roles of p300 in the transcriptional regulation of IL-18. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15543578     DOI: 10.1002/jcb.20194

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  2 in total

1.  CREB-induced inflammation is important for malignant mesothelioma growth.

Authors:  Catherine M Westbom; Anurag Shukla; Maximilian B MacPherson; Elizabeth C Yasewicz; Jill M Miller; Stacie L Beuschel; Chad Steele; Harvey I Pass; Pamela M Vacek; Arti Shukla
Journal:  Am J Pathol       Date:  2014-08-08       Impact factor: 4.307

2.  Distinct licensing of IL-18 and IL-1β secretion in response to NLRP3 inflammasome activation.

Authors:  Rebecca L Schmidt; Laurel L Lenz
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.